S. Stewart

发表

Efficacy of Sandostatin® LAR® (long‐acting somatostatin analogue) is similar in patients with untreated acromegaly and in those previously treated with surgery and/or radiotherapy

P. Stewart, M. Sheppard, J. Ayuk, 2004, Clinical endocrinology.

Long-term safety and efficacy of depot long-acting somatostatin analogs for the treatment of acromegaly.

P. Stewart, M. Sheppard, J. Ayuk, 2002, The Journal of clinical endocrinology and metabolism.

TAC3/TACR3 mutations reveal preferential activation of gonadotropin-releasing hormone release by neurokinin B in neonatal life followed by reversal in adulthood.

R. Quinton, W. Crowley, M. de Castro, 2010, The Journal of clinical endocrinology and metabolism.

Clinical and biochemical response following withdrawal of a long‐acting, depot injection form of octreotide (Sandostatin‐LAR®)

P. Stewart, P. Clark, M. Sheppard, 1999, Clinical endocrinology.

Hypothalamic Reproductive Endocrine Pulse Generator Activity Independent of Neurokinin B and Dynorphin Signaling.

I. Farooqi, T. Cole, R. Talbi, 2019, The Journal of clinical endocrinology and metabolism.

Germline ESR2 mutation predisposes to medullary thyroid carcinoma and causes up-regulation of RET expression.

Rachel M. Brown, M. Simpson, L. Mulligan, 2016, Human molecular genetics.

Long‐term therapy with long‐acting octreotide (Sandostatin‐LAR®) for the management of acromegaly

I. Lancranjan, P. Stewart, M. Sheppard, 1998, Clinical endocrinology.

Significant Benefits of AIP Testing and Clinical Screening in Familial Isolated and Young-onset Pituitary Tumors

Julian R. E. Davis, H. Randeva, R. Eeles, 2020, The Journal of clinical endocrinology and metabolism.

Tumour risks and genotype–phenotype correlations associated with germline variants in succinate dehydrogenase subunit genes SDHB, SDHC and SDHD

Douglas E. V. Pires, Soo-Mi Park, A. Antoniou, 2018, Journal of Medical Genetics.

Depot long-acting somatostatin analog (Sandostatin-LAR) is an effective treatment for acromegaly.

I. Lancranjan, P. Stewart, M. Sheppard, 1995, The Journal of clinical endocrinology and metabolism.

Lithium Carbonate – a Competitive Aldosterone Antagonist?

P. Padfield, P. Stewart, L. Whalley, 1988, British Journal of Psychiatry.